Test to screen Mediterranean family fever in children and adults
Part of Genetic & congenital clinical trials.
This study checks how well a specific blood test works for people who may have Mediterranean family fever (FMF). It may help doctors recognize FMF more accurately and decide on follow-up and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 4 or older (children or adults)
- Your symptoms fit Mediterranean family fever, and you already have an MEFV gene result with a disease-causing (pathogenic) or likely disease-causing (possibly pathogenic) change
- You are newly diagnosed or being followed up for FMF
- You are being treated for FMF, or you are not being treated right now (either is okay)
- A blood test is planned as part of your routine care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at two simple blood test scores (AGE and CALLY) to see if they can help monitor inflammation in people with Familial Mediterranean Fever (FMF). It compares these scores between FMF patients and healthy volunteers to find better ways to track the disease.
This study measures levels of certain proteins (caspase-1, IL-1beta, and IL-18) in tissue samples from people with Familial Mediterranean Fever (FMF). It aims to understand how these proteins relate to the disease and may help guide future treatments.
This trial looks at whether foods like gluten or wheat might cause attacks in people with Familial Mediterranean Fever (FMF). If you have FMF, joining could help understand if changing your diet can prevent attacks.
This trial tests if adding whole-body vibration to vitamin D supplements can improve symptoms in adolescent girls with Familial Mediterranean Fever (FMF). It aims to find a simple, non-drug way to help manage the condition.
This trial tests if a Mediterranean diet plus aerobic exercise can improve fatty liver in women with Familial Mediterranean Fever (FMF) who are also obese. It aims to see if these lifestyle changes help liver health.
This Phase 2 study tests whether RPH-104 can help prevent recurrent fever attacks in adults with Familial Mediterranean Fever (FMF) who cannot tolerate colchicine or whose disease does not respond to it. Participants may receive the medicine at the clinic or learn to give it as a self-injection, depending on what fits your situation.
Hear when a new Familial Mediterranean Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.